4//SEC Filing
INTERCEPT PHARMACEUTICALS INC 4
Accession 0001144204-13-055680
CIK 0001270073operating
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 9:33 PM ET
Size
6.0 KB
Accession
0001144204-13-055680
Insider Transaction Report
Form 4
TALLARIGO LORENZO
Director
Transactions
- Sale
Common Stock
2013-10-15$62.50/sh−1,123,415$70,213,438→ 6,063,802 total(indirect: See Footnote)
Holdings
- 3,111
Common Stock
Footnotes (2)
- [F1]These shares are held by Genextra S.p.A. Dr. Tallarigo is the chief executive officer of Genextra S.p.A. and, in such capacity, Dr. Tallarigo exercises voting control over the shares of common stock owned by Genextra S.p.A. and investment control over such shares as authorized by the board of directors of Genextra S.p.A. Dr. Tallarigo disclaims beneficial ownership with respect to any such shares, except to the extent of his pecuniary interest therein, if any.
- [F2]Represents shares of common stock sold by Genextra S.p.A. in a secondary offering pursuant to a registration statement on Form S-1 (File No. 333-191501) that was completed on October 15, 2013.
Documents
Issuer
INTERCEPT PHARMACEUTICALS INC
CIK 0001270073
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001270073
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 9:33 PM ET
- Size
- 6.0 KB